Heart & long-term risk
Also known as Apolipoprotein B, ApoB-100. Measured in mg/dL.
ApoB, or apolipoprotein B, is a protein that sits on the surface of every cholesterol particle capable of lodging in an artery wall. Each such particle — LDL, VLDL, IDL and Lp(a) — carries exactly one ApoB molecule, so measuring ApoB counts those particles directly rather than weighing the cholesterol inside them. This distinction matters because two people with identical LDL cholesterol can carry very different particle counts, and it is the number of particles colliding with the artery wall that drives plaque formation. Someone with many small, cholesterol-poor particles has a normal-looking LDL result and a high ApoB, and their cardiovascular risk tracks the ApoB. For this reason ApoB is widely regarded as a more reliable single measure of atherogenic risk than LDL cholesterol, and it is increasingly recommended where the two disagree.
Every atherogenic particle — LDL, VLDL, IDL and Lp(a) — carries exactly one ApoB molecule, so ApoB is a direct particle count.
Two people with identical LDL cholesterol can have very different ApoB, and cardiovascular risk follows the ApoB.
Below 80 mg/dL is a common primary-prevention target; below 65 mg/dL where cardiovascular disease or diabetes is established.
A raised ApoB means a high number of atherogenic particles in circulation, and it is the pattern most predictive of future cardiovascular events. It commonly accompanies insulin resistance, a high triglyceride-to-HDL ratio, and abdominal obesity — the cluster in which LDL cholesterol frequently reads normal while particle count does not. Where ApoB is high and LDL is normal, the ApoB is the number to act on.
A low ApoB is generally favourable and is the target of lipid-lowering therapy. Very low values in someone not on treatment are uncommon and occasionally point to an inherited condition affecting lipoprotein production, or to malabsorption; both warrant a physician looking at the wider panel rather than a repeat of this marker alone.
| Band | Value |
|---|---|
| Optimal, primary prevention | < 80 mg/dL |
| Elevated risk | 80 – 100 mg/dL |
| High | > 100 mg/dL |
| Established cardiovascular disease or diabetes | < 65 mg/dLA therapeutic target, not a population range |
Laboratory intervals vary. Interpret with a physician.
Indians develop coronary disease around a decade earlier than Western populations and at lower body weights, and 53.4% of cardiovascular deaths in India occur before the age of 70. Standard lipid panels are calibrated to detect risk in populations where disease arrives later, which is part of why a normal cholesterol report is such a poor reassurance here. ICMR-INDIAB found dyslipidaemia in 81.2% of the adults it sampled — most of whom had never been told.
Lp(a), pronounced "L-P-little-a", is a cholesterol-carrying particle whose blood concentration is set almost entirely by the genes you inherited.
hs-CRP is a high-sensitivity measurement of C-reactive protein, a substance the liver releases in response to inflammation.
Fasting insulin measures how much insulin the pancreas is releasing to hold blood glucose steady after an overnight fast.
HbA1c measures the proportion of haemoglobin in your red blood cells that has sugar attached to it.
ApoB is a risk marker, not a diagnosis, and a single elevated value is not an emergency. Discuss any result above 100 mg/dL with a physician, particularly alongside a family history of early heart disease. Chest pain, breathlessness on exertion or new exercise intolerance need same-day medical attention regardless of what any lipid marker says.
For predicting cardiovascular risk, ApoB is the more informative of the two, because it counts particles rather than measuring the cholesterol they carry. The two usually agree; where they disagree, the ApoB is the number that tracks risk. LDL cholesterol remains useful and is more widely available and cheaper.
ApoB is relatively insensitive to a recent meal compared with triglycerides, and non-fasting samples are acceptable in most guidelines. Peak Brain draws it as part of a fasted panel because the other markers read alongside it — fasting glucose, insulin and triglycerides — do require a fast.
Yes, though the size of the response varies. Reducing saturated fat and refined carbohydrate, losing visceral fat and improving insulin sensitivity all lower particle count. Where ApoB is substantially elevated or there is a strong family history, lifestyle change alone is often insufficient and a physician may discuss medication.
The programme
Peak Brain draws a full blood and urine panel at your home, has a licensed physician read every marker together rather than one at a time, and turns what they find into a ranked 90-day protocol with a retest at the end.
Authorship & review
Written by the Peak Brain clinical team. Assigned clinical reviewer: Dr. Nitesh Arora, MD, DM — review pending; this page has not yet been signed off.
Published . Last updated .
This page is general health information, not medical advice, diagnosis or treatment. Reference ranges vary between laboratories. Never delay or disregard advice from a qualified health professional because of something you read here. If you think you may have a medical emergency, call your local emergency number.